Follow-on offering Announced
Amylyx Pharmaceuticals equity raising
US$575m raised
Announced 25 Aug 2026 · NASDAQ: AMLX
Advisers
Amylyx Pharmaceuticals
Issuer
- Legal adviser
Lead managers
- Issuer
- Amylyx Pharmaceuticals
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Kailera Therapeutics IPO Apr 2026 · US$625m · Biotech
- Candid Therapeutics placement Mar 2026 · US$505m · Biotech
- Parabilis Medicines IPO Jun 2026 · US$670m · Biotech
- ADARx Pharmaceuticals IPO Sep 2026 · US$446m · Biotech
- Generate Biomedicines IPO Feb 2026 · US$400m · Biotech
Sources
- 25 Aug 2026 Goodwin Advises Amylyx Pharmaceuticals on $575 Million Public Offering goodwinlaw.com

